The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study

Mohammadreza Sobhan,1 Mahsa Hojati,2 Seyed-Yaser Vafaie,3 Davoud Ahmadimoghaddam,4 Younes Mohammadi,5 Maryam Mehrpooya2 1Psoriasis Research Center, Department of Dermatology, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran; 2Department of Clinical Pharmacy, School of Pharm...

Full description

Bibliographic Details
Main Authors: Sobhan M, Hojati M, Vafaie SY, Ahmadimoghaddam D, Mohammadi Y, Mehrpooya M
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/the-efficacy-of-colloidal-oatmeal-cream-1-as-add-on-therapy-in-the-man-peer-reviewed-article-CCID
id doaj-a4967694929442b09fa8407d162e3964
record_format Article
spelling doaj-a4967694929442b09fa8407d162e39642020-11-25T02:05:08ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152020-03-01Volume 1324125152723The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind StudySobhan MHojati MVafaie SYAhmadimoghaddam DMohammadi YMehrpooya MMohammadreza Sobhan,1 Mahsa Hojati,2 Seyed-Yaser Vafaie,3 Davoud Ahmadimoghaddam,4 Younes Mohammadi,5 Maryam Mehrpooya2 1Psoriasis Research Center, Department of Dermatology, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran; 2Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 3Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 4Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 5Modeling of Noncommunicable Diseases Research Center, School of Public Health, Hamadan University of Medical Sciences, Hamadan, IranCorrespondence: Maryam MehrpooyaDepartment of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan 6517838678, IranTel +98 81 3821 868Fax +98-8138381591Email m_mehrpooya2003@yahoo.comBackground: Irritant contact dermatitis (ICD) is the most frequent cause of hand eczema (HE). There is promising evidence with the use of topical oatmeal compounds in the management of inflammation- and itch-responses associated with diverse dermatologic conditions. This study aimed to evaluate the clinical benefit of colloidal oatmeal cream in the management of chronic irritant HE.Methods: From October 2018 to November 2019, 79 patients with diagnosis of chronic irritant HE were allocated into either intervention or control groups by block randomization method. Besides fluocinolone 0.025% ointment for the first 2 weeks of treatment period, patients in the intervention and control groups were asked to use colloidal oatmeal 1% cream or base cream for additional 4 weeks as monotherapy. Changes in the HE severity based on the hand eczema severity index (HESCI) score, pruritus severity based on the visual analogue scale (VAS), and impact of skin disorder on patients quality of life based on the Dermatology Life Quality Index (DLQI) from baseline to weeks 2, 4, and 6 were assessed in the study groups.Results: Fifty subjects, 26 in intervention and 24 in control, completed the course of the study. The results indicated, though relatively comparable decrease in mean HESI and VAS scores was observed in both groups by the end of week 2, thereafter until end of the study a non-return of symptoms to baseline conditions was observed in the intervention group, while there was a significant return of symptoms to baseline conditions in the control group (p value< 0.001 in both conditions). Further, a noticeable improvement in the DLQI score was seen in the intervention group compared with the control group (p value< 0.001).Conclusion: Findings demonstrate that colloidal oatmeal, a natural product with proven barrier protection, moisturization, anti-inflammatory, and soothing properties, can have ameliorative effects on eczema severity symptoms in patients with chronic irritant HE.Keywords: hand eczema, irritant contact dermatitis, colloidal oatmeal, Hand Eczema Severity Index; Dermatology Life Quality Indexhttps://www.dovepress.com/the-efficacy-of-colloidal-oatmeal-cream-1-as-add-on-therapy-in-the-man-peer-reviewed-article-CCIDhand eczemairritant contact dermatitiscolloidal oatmealhand eczema severity indexdermatology life quality index
collection DOAJ
language English
format Article
sources DOAJ
author Sobhan M
Hojati M
Vafaie SY
Ahmadimoghaddam D
Mohammadi Y
Mehrpooya M
spellingShingle Sobhan M
Hojati M
Vafaie SY
Ahmadimoghaddam D
Mohammadi Y
Mehrpooya M
The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study
Clinical, Cosmetic and Investigational Dermatology
hand eczema
irritant contact dermatitis
colloidal oatmeal
hand eczema severity index
dermatology life quality index
author_facet Sobhan M
Hojati M
Vafaie SY
Ahmadimoghaddam D
Mohammadi Y
Mehrpooya M
author_sort Sobhan M
title The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study
title_short The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study
title_full The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study
title_fullStr The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study
title_full_unstemmed The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study
title_sort efficacy of colloidal oatmeal cream 1% as add-on therapy in the management of chronic irritant hand eczema: a double-blind study
publisher Dove Medical Press
series Clinical, Cosmetic and Investigational Dermatology
issn 1178-7015
publishDate 2020-03-01
description Mohammadreza Sobhan,1 Mahsa Hojati,2 Seyed-Yaser Vafaie,3 Davoud Ahmadimoghaddam,4 Younes Mohammadi,5 Maryam Mehrpooya2 1Psoriasis Research Center, Department of Dermatology, Farshchian Hospital, Hamadan University of Medical Sciences, Hamadan, Iran; 2Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 3Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 4Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran; 5Modeling of Noncommunicable Diseases Research Center, School of Public Health, Hamadan University of Medical Sciences, Hamadan, IranCorrespondence: Maryam MehrpooyaDepartment of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan 6517838678, IranTel +98 81 3821 868Fax +98-8138381591Email m_mehrpooya2003@yahoo.comBackground: Irritant contact dermatitis (ICD) is the most frequent cause of hand eczema (HE). There is promising evidence with the use of topical oatmeal compounds in the management of inflammation- and itch-responses associated with diverse dermatologic conditions. This study aimed to evaluate the clinical benefit of colloidal oatmeal cream in the management of chronic irritant HE.Methods: From October 2018 to November 2019, 79 patients with diagnosis of chronic irritant HE were allocated into either intervention or control groups by block randomization method. Besides fluocinolone 0.025% ointment for the first 2 weeks of treatment period, patients in the intervention and control groups were asked to use colloidal oatmeal 1% cream or base cream for additional 4 weeks as monotherapy. Changes in the HE severity based on the hand eczema severity index (HESCI) score, pruritus severity based on the visual analogue scale (VAS), and impact of skin disorder on patients quality of life based on the Dermatology Life Quality Index (DLQI) from baseline to weeks 2, 4, and 6 were assessed in the study groups.Results: Fifty subjects, 26 in intervention and 24 in control, completed the course of the study. The results indicated, though relatively comparable decrease in mean HESI and VAS scores was observed in both groups by the end of week 2, thereafter until end of the study a non-return of symptoms to baseline conditions was observed in the intervention group, while there was a significant return of symptoms to baseline conditions in the control group (p value< 0.001 in both conditions). Further, a noticeable improvement in the DLQI score was seen in the intervention group compared with the control group (p value< 0.001).Conclusion: Findings demonstrate that colloidal oatmeal, a natural product with proven barrier protection, moisturization, anti-inflammatory, and soothing properties, can have ameliorative effects on eczema severity symptoms in patients with chronic irritant HE.Keywords: hand eczema, irritant contact dermatitis, colloidal oatmeal, Hand Eczema Severity Index; Dermatology Life Quality Index
topic hand eczema
irritant contact dermatitis
colloidal oatmeal
hand eczema severity index
dermatology life quality index
url https://www.dovepress.com/the-efficacy-of-colloidal-oatmeal-cream-1-as-add-on-therapy-in-the-man-peer-reviewed-article-CCID
work_keys_str_mv AT sobhanm theefficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT hojatim theefficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT vafaiesy theefficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT ahmadimoghaddamd theefficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT mohammadiy theefficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT mehrpooyam theefficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT sobhanm efficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT hojatim efficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT vafaiesy efficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT ahmadimoghaddamd efficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT mohammadiy efficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
AT mehrpooyam efficacyofcolloidaloatmealcream1asaddontherapyinthemanagementofchronicirritanthandeczemaadoubleblindstudy
_version_ 1724939744615333888